✨ The FDA has approved updated COVID-19 vaccines for the fall & winter season — but access is limited. ✅ Seniors 65+ & people 5+ with certain health conditions qualify. ❌ Children under 5 no longer do. A major shift, so check with your doctor or pharmacy for eligibility.

This month, VantAI and Halda Therapeutics announced a groundbreaking partnership worth up to $1 billion to accelerate proximity-based drug development using VantAI’s AI-driven proteomics platform. A major step in biotech and AI innovation.

Exciting oncology news! The FDA approved Linvoseltamab-gcpt for multiple myeloma, and a patient was successfully treated with dostarlimab for colorectal cancer. Advances in KRAS inhibitors, molecular glues, and biotech growth in Vienna are fueling hope for future breakthroughs. #Oncology

Over the past 20 years, CD40 agonist antibodies showed promise in activating the immune system against cancer, but in clinical trials, they had limited effectiveness and caused serious side effects like inflammation, low platelets, and liver toxicity.